KLA peptide
KLA peptide is a naturally occurring Antibiotic peptide that is nontoxic outside of cells but is toxic when it enters into the interior of targeted cells. KLA peptide can induce cell Apoptosis by disrupting mitochondrial membranes and activating Caspase. MG1-KLA, formed by the coupling of KLA peptide with MG1, can selectively induce apoptosis in pro-inflammatory microglia. KLA peptide can be used for the research of liver fibrosis. KLA peptide can be used for the research of neonatal hypoxic-ischemic encephalopathy.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 184240-26-4
- Fòrmula: C72H138N20O15
- Peso molecular:1523.99
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas Antibiotic
MoreVer todos los productos específicos de isoformas Caspase
More
Actividad biológica
When acting alone, the KLA peptide (in FITC-KLA form; 50-200 μM; 30 min) exhibits negligible cell-penetrating activity in HSC-T6 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 184240-26-4
-
Peso molecular 1523.99
-
Fòrmula C72H138N20O15
-
Sequence
Lys-Leu-Ala-Lys-Leu-Ala-Lys-Lys-Leu-Ala-Lys-Leu-Ala-Lys
-
Sequence Shortening
KLAKLAKKLAKLAK
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Guo Z, et al. Specific hepatic stellate cell-penetrating peptide targeted delivery of a KLA peptide reduces collagen accumulation by inducing apoptosis. J Drug Target. 2017;25(8):715-723. [Content Brief]
[2]. Zen R, et al. Pro-inflammatory microglia-targeted peptide therapy ameliorates neonatal hypoxic-ischemic encephalopathy in mice. Mol Ther. 2025;33(7):3177-3194. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)